Abstract
This review focuses on clinical studies employing recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), because these two hematopoietic factors have been the most extensively investigated.
Original language | English (US) |
---|---|
Pages (from-to) | 163-170 |
Number of pages | 8 |
Journal | Current opinion in oncology |
Volume | 2 |
Issue number | 1 |
DOIs | |
State | Published - 1990 |
ASJC Scopus subject areas
- Oncology
- Cancer Research